Abstract
To investigate the binding mode of Zolpidem to GABAA and to delineate the conformational changes induced upon agonist binding, we carried out atomistic molecular dynamics simulation using the ligand binding domain of GABAA α1 receptor. Comparative molecular dynamics simulation of the apo and the holo form of GABAA receptor revealed that γ2/α1 interface housing the benzodiazepine binding site undergoes distinct conformational changes upon Zolpidem binding. We notice that C loop of the α1 subunit experiences an inward motion toward the vestibule and the F loop of γ2 sways away from the vestibule, an observation that rationalizes Zolpidem as an alpha1 selective agonist. Energy decomposition analysis carried out was able to highlight the important residues implicated in Zolpidem binding, which were largely in congruence with the experimental data. The simulation study disclosed herein provides a meaningful insight into Zolpidem-GABAAR interactions and helps to arrive at a binding mode hypothesis with implications for drug design.
Similar content being viewed by others
References
Kuffler SW, Edwards C (1958) Mechanism of gamma aminobutyric acid (GABA) action and its relation to synaptic inhibition. J Neurophysiol 21:589–610
Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA et al (1987) Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature 328:221–227
Smith GB, Olsen RW (1995) Functional domains of GABAA receptors. Trends Pharmacol Sci 16:162–168
Clayton T, Chen JL, Ernst M, Richter L, Cromer BA, Morton CJ, Ng H, Kaczorowski CC, Helmstetter FJ, Furtmuller R, Ecker G, Parker MW, Sieghart W, Cook JM (2007) An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models. Curr Med Chem 14:2755–2775
Ernst M, Bruckner S, Boresch S, Sieghart W (2005) Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 68:1291–1300
Curtis DR (1978) In: Krogsgaard-Larsen P, Scheel-Kruger J, Kofoed H (eds) GABA Neurotransmitters: Pharmacochemical Biochemical and Pharmacological Aspects, Munksgaard, Kopenhagen
Darcourt G, Pringuey D, Salliere D, Lavoisy J (1999) The safety and tolerability of zolpidems an update. J Psychopharmacol 13:81–93
Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Biggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 451:103–110
Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131–134
Ghoshal N, Vijayan RSK (2010) Pharmacophore models for GABAA modulators: implications in CNS drug discovery. Expert Opin Drug Discov 5:441–460
Hanson SM, Morlock EV, Satyshur KA, Czajkowski C (2008) Structural requirement for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem 51:7243–7252
Renard S, Olivier A, Granger P, Avenet P, Graham D, Sevrin M, George P, Besnard F (1999) Structural elements of the gamma-aminobutyric acid type A receptor conferring subtype selectivity for benzodiazepine site ligands. J Biol Chem 274:13370–13374
Buhr A, Baur R, Sigel E (1997) Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J Biol Chem 272:11799–11804
Mihic SJ, Whiting PJ, Klein RL, Wafford KA, Harris RA (1994) A single amino acid of the human gamma-aminobutyric acid type A receptor gamma 2 subunit determines benzodiazepine efficacy. J Biol Chem 269:32768–32773
Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK (2001) Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411:269–276
Ernst M, Brauchart D, Boresch S, Sieghart W (2003) Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience 119:933–943
Amadei A, Linssen AB, Berendsen HJ (1993) Essential dynamics of proteins. Proteins 17:412–425
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701–1718
Schuttelkopf AW, van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60:1355–1363
TSAR, Version 3.0 (2007) Accelrys Inc, San Diego, CA
Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 23:1623–1641
Berendsen HJC, Postma JPM, van Gunsteren WF, Dinola A, Haak JR (1984) Molecular- dynamics with coupling to an external bath. J Chem Phys 81:3684–3690
Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52:7182–7190
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N · log(N) method for Ewald Sums in large systems. J Chem Phys 98:10089–10092
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38
Smart OS, Neduvelil JG, Wang X, Wallace BA, Sansom MS (1996) HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J Mol Graph 14:354–360
Henchman RH, Wang HL, Sine SM, Taylor P, McCammon JA (2005) Ligand-Induced conformational change in the alpha7 nicotinic receptor ligand binding domain. Biophys J 88:2564–2576
Khatri A, Sedelnikova A, Weiss DS (2009) Structural rearrangements in loop F of the GABA receptor signal ligand binding, not channel activation. Biophys J 96:45–55
Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127–134
Amin J, Brooks-Kayal A, Weiss DS (1997) Two tyrosine residues on the alpha subunit are crucial for benzodiazepine binding and allosteric modulation of gamma-aminobutyric acid A receptors. Mol Pharmacol 51:833–841
Karlin A, Akabas MH (1995) Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 15:1231–1244
Padgett CL, Lummis SC (2008) The F-loop of the GABA A receptor gamma2 subunit contributes to benzodiazepine modulation. J Biol Chem 283:2702–2708
Acknowledgments
R.S.K.V thanks Council of Scientific and Industrial Research (CSIR), New Delhi for a Research Associateship. N.G. is thankful to CSIR Mission Mode Program (CMM-0017) for providing financial assistance. Software support granted by OpenEye is greatly acknowledged. We acknowledge Mr. Robert Schulz for providing scripts to generate Porcupine Plots.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Figure SI1
Plot of temperature, total energy and pressure as a function of time (DOC 110 kb)
Figure SI2
RMSF values of the Cα atoms for the chain B (β2), chain C (α1) and D (β2) of the apo form (red) and holo form (green) (DOC 102 kb)
Figure SI3
Change in pore diameter plotted as a function of time for the vestibular region. (DOC 211 kb)
Figure SI4
Librational motion of the aromatic side chains of the BZ site during the MD simulation. (DOC 117 kb)
Rights and permissions
About this article
Cite this article
Vijayan, R.S.K., Bhattacharyya, D. & Ghoshal, N. Deciphering the binding mode of Zolpidem to GABAA α1 receptor – insights from molecular dynamics simulation. J Mol Model 18, 1345–1354 (2012). https://doi.org/10.1007/s00894-011-1142-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-011-1142-0